| Literature DB >> 22318899 |
Sameh Magdeldin1, Tadashi Yamamoto.
Abstract
Formalin-fixed paraffin-embedded (FFPE) tissue specimens comprise a potentially valuable resource for both prospective and retrospective biomarker discovery. Unlocking the proteomic profile of clinicopathological FFPE tissues is a critically essential step for annotating clinical findings and predicting biomarkers for ultimate disease prognosis and therapeutic follow-up.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22318899 PMCID: PMC3561704 DOI: 10.1002/pmic.201100550
Source DB: PubMed Journal: Proteomics ISSN: 1615-9853 Impact factor: 3.984
Figure 1Structural organization and probable changes that proteins undergo in formalin-fixed, paraffin-embedded (FFPE) sections. aa, amino acid; pI, isoelectric point; Mw, molecular weight.
Figure 2Schematic view of the most probable formaldehyde-induced modifications in FFPE proteins. Reactive methylol adducts (Δm = 30 Da) are formed as a result of the interaction between formaldehyde and basic amino acid residues, amide groups, or aromatic rings. Unsaturated Schiff base “azomethine” adducts (Δm = 12 Da) are formed as a result of condensation of amino groups with aldehydes or ketones, a reversible reaction with the methylol adduct. Other modification involves formation of acetals. R, organic side chain.
Figure 3Hypothetical production of peptides generated from FFPE tissues, with their identification success. Following endopeptidase digestion of FFPE specimens, three different types of peptides (based on amino acid modifications and cross-linking) are produced with a varying percentage of identification success: nonmodified peptides, which are likely to be successfully identified (high percentage); modified, noncross-linked peptides, where the success of its identification relies mainly on the variable modification setting of the search engine; and cross-linked peptides, which exhibit a complex form with altered physiochemical properties that make its matching percentage in the in silico database a hard task, with a low percentage of success.
Figure 4Schematic diagram showing the importance of cleaving methylene bridges of FFPE protein extracts for proper endopeptidase digestion. Methylene bridges prevent trypsin or other endopeptidases reaching its active cleaving site, leading to improper digestion and the existence of cross-linked peptides.
Figure 5A flowchart of generalized workflow adopted for extraction and MS identification of FFPE tissues. A defined area of mounted sections is deparaffinized for xylene removal, followed by hydration with an ascending series of ethanol. A specified region of interest captured by laser capture microdisection (LCM) or deparaffinized, hydrated block are subjected to proper protein extraction at a determined pressure/temperature. Samples are then reduced and alkylated (optional) and subjected to enzymatic digestion. Further desalting and purification is required to remove denaturant/detergent and to reduce the noise background during MS analysis. Inclusion of prefractionation is sometimes required to reduce sample complexity. Finally, output MS results are searched against a defined database. A variable modification of hydroxyl (CH2OH) with [Δ = +30 Da] can be set for the lysine residue in the MS/MS search.
Figure 6Assessment of FFPE sample fixation time, storage time, and extraction buffer variability on protein identification and yield by shotgun LC-MS/MS. (A) Effect of fixation time on the number of identified proteins. (B) Effect of storage time on the number of identified proteins. Error bars represent SD, (n = 9) for both (A) and (B). *** indicates significant different from all groups (p<0.001). (C) Electrophoretic pattern of 20-μg FFPE mouse heart tissue extracted with different extraction buffers and stained with Coomassie. (a) Tris buffer containing 1% β-octylglucoside; (b) 2% CHAPS; (c) Laemmli buffer containing 2% SDS; (d) RIPA buffer containing 2% SDS and 1% NP40; (e, h) acidic Tris buffer containing glycine and 2% SDS (e) or 0.2% Tween 20 (h); (f, g) neutral Tris buffer containing glycine, 2% SDS, and 1% NP40 (f) or 0.2% Tween 20 (g); (i, j) basic Tris buffer containing 2% SDS, 0.2% Tween 20, glycine, with DTT (i) or without DTT (j); (k) commercially FFPE extraction buffer (Qproteome FFPE tissue kit, Qiagen, Germany); (l) basic Tris buffer containing 2% SDS, 1% ß-octylglucoside, DTT, and glycine (reproduced with permission from Refs. [13] and [17]).
Summary of previous proteomic experiments utilizing FFPE specimens, excluding studies on full-length proteins
| Reference no. | Sample | Sample size | Lysis buffer | Temp | Reduction and alkylation | Enzyme/protein | Protein identified | Desalted/enriched | Remark |
|---|---|---|---|---|---|---|---|---|---|
| 11 | Human lymphoma cell line | 600 μg | RIPA with 0.1% SDS | Yes | No | 1:50 | 324 | Yes | |
| 13 | Human colon adenoma | 200 μg | TFE | Yes | R/A (e) | 1:50 | 400 | Yes | |
| 17 | Mouse heart | 20 μm, 80 mm2 wide | 2% SDS, 1% ß-Octyl glycoside in pH 8.8 | Yes | Yes | 1:20 | 192 | Yes | |
| 19 | Mouse liver | N/A | 6 M Guanidine-HCL | No | R/A | 1:50 | 130 | Yes | |
| 19 | Mouse liver | N/A | 2% SDS in pH 8.2 buffer | Yes | R/A | 1:50 | 820 | Yes | |
| 19 | Mouse liver | N/A | 6 M Guanidine-HCL | Yes | R/A | 1:50 | 827 | N/A | |
| 23 | Sheep skeletal muscle | 10 μm, 80 μm wide | 20 mM Tris, 2% SDS | Yes | Yes | 60–100 ng | 66 | No | |
| 200 mM DTT pH 8.8 | |||||||||
| 41 | Human renal carcinoma | 10 μm section | 2% SDS in pH 7 buffer | Yes | N/A | N/A | 3263 | Yes | b,
|
| 41 | Human renal carcinoma | 10 μm section | 2% SDS in pH 9 buffer | Yes | N/A | N/A | 3254 | Yes | |
| 41 | Human renal carcinoma | 10 μm section | 2% SDS in pH 9 buffer | No | N/A | N/A | 1883 | Yes | |
| 42 | Canalplasty and temporal bone | N/A | 2% SDS in 100 mM ABC pH 8.5 | Yes | Yes | N/A | 123 | Yes | |
| 43 | Human liver | 1 × 1 cm 10 μm | 20 mM Tris, 2% SDS pH 9.0 | Yes | Yes | 1:40 | 3350 | Yes | |
| 51 | Coronary vessels | 5–10 μm | 30% ACN in 100 mM | Yes | No | 12 ng/μL | 710 | No | |
| 53 | Rat liver | 7 × 3 cm 7 μm | 1M Tris, 2 M sucrose, 0.5 M EDTA, 1 M DTT | Yes | Yes | 1:20 | 132 | No |
The table is not for comparative purposes. However, it shows in glance some FFPE experimental workflow with summarized protein identification.
Reduction and alkylation with dithiothretiol (DTT) and iodoacetamide (IAA), respectively, unless stated otherwise.
Total protein identification with at least one peptide.
Samples were digested with trypsin and Glu-C.
Samples were desalted with Sep-Pak Vac C18 cartilage.
Samples were reduced with carboxyethylphosphine and DTT.
Samples were purified using C18 ZipTip.
Samples were enriched with an SCX trap column.
Samples were fractionated on SDS-PAGE.
Samples were dialyzed and analyzed by an online combination of CIEF/LC-MS/MS.
Peptides were cleaned with Oasis MCX column.
Peptides were desalted using peptide microTrap column and analyzed by CITP/CZE coupled with nano-RPLC.
Figure 7Effect of pH, temperature, and glycerol addition on protein extraction and yield from 20-μm thick human prostate FFPE sections and a tissue surrogate model. (A) Electrophoretic pattern of proteins extracted from FFPE sections with 1–2% SDS-containing buffers at pH 7.6, 8.0, and 9.9 at 115°C for 15 min. (B) Patterns for 20-μm FFPE sections dissolved in 200 μL RIPA buffer containing 1% SDS and incubated at 4, 25, 37, and 65°C for 3 h. Both images in (A) and (B) were stained with silver staining kit. (C) SDS-PAGE of protein extracted from FFPE lysozyme tissue surrogates retrieved at different incubation temperatures. The 80°C sample was incubated for 2 h, while samples extracted at 100 and 121°C were incubated for 20 min, followed by cycle heating at 60°C for 2 h. (D) Improved extraction consistency can be demonstrated on addition of 10% glycerol to the FFPE extraction buffer. Samples were measured using the bicinchoninic acid (BCA) protein assay, based on three independent extractions (reproduced with permission from Refs. [9] and [30]).